Inventor
STIRLING DAVID I
US47 patents
⚠️ This page may combine multiple inventors who share the name “STIRLING DAVID I”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
36 patentsUS6555554B2Apr 29, 2003
Isoindolines, method of use, and pharmaceutical compositions
CELGENE CORP245 citations99
US6476052B1Nov 5, 2002
Isoindolines, method of use, and pharmaceutical compositions
CELGENE CORP295 citations99
US6395754B1May 28, 2002
Substituted 2-(2,6-dioxopiperidin-3-yl)- phthalimides and 1-oxoisoindolines and method of reducing TNFα levels
CELGENE CORP296 citations99
US6335349B1Jan 1, 2002
Substituted 2(2,6-dioxopiperidin-3-yl)isoindolines
CELGENE CORP301 citations99
US6316471B1Nov 13, 2001
Isoindolines, method of use, and pharmaceutical compositions
CELGENE CORP334 citations99
US6281230B1Aug 28, 2001
Isoindolines, method of use, and pharmaceutical compositions
CELGENE CORP400 citations99
US6046221AApr 4, 2000
Immunotherapeutic aryl amides
CELGENE CORP108 citations99
US5955476ASep 21, 1999
Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
CELGENE CORP267 citations99
US5908850AJun 1, 1999
Method of treating attention deficit disorders with d-threo methylphenidate
CELGENE CORP211 citations99
US5874448AFeb 23, 1999
Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels
CELGENE CORP285 citations99
US5801195ASep 1, 1998
Immunotherapeutic aryl amides
CELGENE CORP121 citations99
US5798368AAug 25, 1998
Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNFα levels
CELGENE CORP305 citations99
US5736570AApr 7, 1998
Immunotherapeutic aryl amides
CELGENE CORP114 citations99
US5703098ADec 30, 1997
Immunotherapeutic imides/amides
CELGENE CORP113 citations98
US5635517AJun 3, 1997
Method of reducing TNFα levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines
CELGENE CORP643 citations97
US5300437AApr 5, 1994
Enantiomeric enrichment and stereoselective synthesis of chiral amines
CELGENE CORP120 citations97
US7119106B2Oct 10, 2006
Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
CELGENE CORP53 citations96
US7041680B2May 9, 2006
(R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the same
CELGENE CORP38 citations96
US4950606AAug 21, 1990
Enantiomeric enrichment and stereoselective synthesis of chiral amines
CELGENE CORP89 citations96
US5346828ASep 13, 1994
Stereoisomeric enrichment of 2-amino-3-hydroxy-3-phenylpropionic acids using d-threonine aldolase
CELGENE CORP55 citations95
US7709502B2May 4, 2010
Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines
CELGENE CORP24 citations93
US7629360B2Dec 8, 2009
Methods for the treatment of cachexia and graft v. host disease
CELGENE CORP21 citations93
US5169780ADec 8, 1992
Enantiomeric enrichment and stereoselective synthesis of chiral amines
CELGENE CORP89 citations93
US6844359B2Jan 18, 2005
Substituted imides
CELGENE CORP14 citations92
US6762195B2Jul 13, 2004
Pharmaceutically active isoindoline derivatives
CELGENE CORP29 citations92
US6486177B2Nov 26, 2002
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
CELGENE CORP31 citations92
US6429221B1Aug 6, 2002
Substituted imides
CELGENE CORP38 citations92
US6284780B1Sep 4, 2001
Immunotherapeutic aryl amides
CELGENE CORP32 citations92
US5733756AMar 31, 1998
Lactams and processes for stereoselective enrichment of lactams, amides, and esters
CELGENE CORP46 citations92
US7115631B2Oct 3, 2006
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
CELGENE CORP39 citations90
US7459466B2Dec 2, 2008
Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing TNFα levels
CELGENE CORP12 citations84
US5071976ADec 10, 1991
Novel heteropolysaccharide
CELGENE CORP13 citations74
US7005438B2Feb 28, 2006
Pharmaceutically active isoindoline derivatives
CELGENE CORP3 citations62
US5166060ANov 24, 1992
Process for the preparation of pyridine-2,3-dicarboxylic acids
CELGENE CORP2 citations56
US7834033B2Nov 16, 2010
Methods for treating cancer using 3-[1,3dioxo-4-benzamidoisoindolin-2-yl]-2,6-dioxo-5-hydroxypiperidine
CELGENE CORP0 citations52
US7329761B2Feb 12, 2008
Substituted imides
CELGENE CORP0 citations52